Welcome to Psychiatryai.com: Latest Evidence - RAISR4D

Estimated reading time for CME/CPD: 2 mins

Accelerated DMN-targeted cTBS improves processing speed deficits in schizophrenia

AI Summary
  • Accelerated DMN-targeted continuous theta burst stimulation (cTBS) improved processing speed in individuals with schizophrenia (p = 0.0124).
  • Reduction in Default Mode Network connectivity was associated with processing speed improvement in schizophrenia (p = 0.021).
  • Age moderated treatment response; younger participants experienced greater processing speed gains following cTBS than older participants (p = 0.006).
Summarise with AI (MRCPsych/FRANZCP)

Mol Psychiatry. 2026 Aug 5. doi: 10.1038/s41380-026-03798-8. Online ahead of print.

ABSTRACT

Cognitive deficits are a leading cause of disability in schizophrenia and are linked to poor functional outcomes. There are no first line treatments for these deficits, and their neural basis is poorly understood. While schizophrenia is associated with widespread cognitive deficits, information processing speed is most profoundly impaired. Processing speed deficits have been associated with hyperconnectivity in the Default Mode Network (DMN). We therefore tested if modulating DMN connectivity with single or multiple sessions of transcranial magnetic stimulation (TMS) applied to an individualized DMN target would affect processing speed. In the first study, 10 individuals with schizophrenia received single TMS sessions and underwent resting-state neuroimaging and processing speed assessment (Brief Assessment of Cognition in Schizophrenia digit symbol coding) acutely before and after each session. These sessions included excitatory (intermittent theta burst stimulation, iTBS); inhibitory (continuous theta burst stimulation, cTBS); and sham stimulation sessions. In the second study, 29 individuals (17 schizophrenia, 12 non-psychosis controls) received 5 accelerated sessions of cTBS with resting-state neuroimaging and processing speed assessment before and after the course of TMS sessions. In the accelerated, multi-session DMN-targeted TMS trial, cTBS improved processing speed in the schizophrenia group (p = 0.0124). In individuals with schizophrenia, reduction in DMN connectivity was linked to improvement in processing speed (p = 0.021). These changes were dependent on age, where younger participants experienced greater processing speed improvements than older participants (p = 0.006). In sum, personalized network targeted TMS may be a novel method for reducing cognitive impairment associated with schizophrenia.

PMID:42557392 | DOI:10.1038/s41380-026-03798-8

Document this CPD

Share Evidence Blueprint

QR Code

Save to Google Notes

Search Google Scholar

Save as PDF

My Revision List

close chatgpt icon
ChatGPT

Enter your request.

Psychiatry AI: Real-Time AI Scoping Review
← →
RAISR4D CME/CPD Evidence Nodes
Swipe to navigate RAISR4D CME/CPD evidence nodes.
CME/CPD